NovoLog Mix 70/30 (Novo Nordisk)
Welcome to the PulseAid listing for the NovoLog Mix 70/30 drug offered from Novo Nordisk. This Insulin [Chemical/Ingredient],Insulin Analog [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Novo Nordisk |
NON-PROPRIETARY NAME: | insulin aspart |
SUBSTANCE NAME: | INSULIN ASPART |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Insulin [Chemical/Ingredient],Insulin Analog [EPC] |
ROUTE: | SUBCUTANEOUS |
DOSAGE FORM: | INJECTION, SUSPENSION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2001-11-01 |
END MARKETING DATE: | 0000-00-00 |
NovoLog Mix 70/30 HUMAN PRESCRIPTION DRUG Details:
Item Description | NovoLog Mix 70/30 from Novo Nordisk |
LABELER NAME: | Novo Nordisk |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 100([iU]/mL) |
START MARKETING DATE: | 2001-11-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0169-3685_40f7ed5e-e45f-4ff7-837e-f7f05dccb92c |
PRODUCT NDC: | 0169-3685 |
APPLICATION NUMBER: | NDA021172 |
Other INSULIN ASPART Pharmaceutical Manufacturers / Labelers: